A citation-based method for searching scientific literature

Nehmat Houssami, Daniela Ambrogetti, M Luke Marinovich, Simonetta Bianchi, Petra Macaskill, Vania Vezzosi, Eleftherios P Mamounas, Stefano Ciatto. Ann Surg Oncol 2011
Times Cited: 29







List of co-cited articles
133 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.
Meagan E Brennan, Robin M Turner, Stefano Ciatto, M Luke Marinovich, James R French, Petra Macaskill, Nehmat Houssami. Radiology 2011
206
72

Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates.
R J Jackman, F Burbank, S H Parker, W P Evans, M C Lechner, T R Richardson, A A Smid, H B Borofsky, C H Lee, H M Goldstein,[...]. Radiology 2001
248
48

Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy.
Sophie Schulz, Peter Sinn, Michael Golatta, Geraldine Rauch, Hans Junkermann, Florian Schuetz, Christof Sohn, Joerg Heil. Breast 2013
34
48


Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ.
Emil D Kurniawan, Allison Rose, Arlene Mou, Malcolm Buchanan, John P Collins, Matthew H Wong, Julie A Miller, G Bruce Mann. Arch Surg 2010
53
44

Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
Tina W F Yen, Kelly K Hunt, Merrick I Ross, Nadeem Q Mirza, Gildy V Babiera, Funda Meric-Bernstam, S Eva Singletary, W Fraser Symmans, Sharon H Giordano, Barry W Feig,[...]. J Am Coll Surg 2005
198
44

Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.
Amit Goyal, Anthony Douglas-Jones, Ian Monypenny, Helen Sweetland, Guy Stevens, Robert E Mansel. Breast Cancer Res Treat 2006
92
41

Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision.
Jisun Kim, Wonshik Han, Jong Won Lee, Jee-Man You, Hee-Chul Shin, Soo Kyung Ahn, Hyeong-Gon Moon, Nariya Cho, Woo Kyung Moon, In-Ae Park,[...]. Breast 2012
39
41


Indication for sentinel lymph node biopsy for breast cancer when core biopsy shows ductal carcinoma in situ.
Tomohiro Miyake, Kenzo Shimazu, Hiroshi Ohashi, Tetsuya Taguchi, Satsuki Ueda, Takahiro Nakayama, Seung Jin Kim, Katsuyuki Aozasa, Yasuhiro Tamaki, Shinzaburo Noguchi. Am J Surg 2011
31
31

Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: experience of 733 cases.
Chiara Trentin, Valeria Dominelli, Patrick Maisonneuve, Simona Menna, Barbara Bazolli, Alberto Luini, Enrico Cassano. Breast 2012
31
31


Sonographic lesion size of ductal carcinoma in situ as a preoperative predictor for the presence of an invasive focus.
Jong Won Lee, Wonshik Han, Eunyoung Ko, Jihyoung Cho, Eun-Kyu Kim, So-Youn Jung, Nariya Cho, Woo Kyung Moon, In-Ae Park, Dong-Young Noh. J Surg Oncol 2008
37
27

An update of sentinel lymph node mapping in patients with ductal carcinoma in situ.
Caren Wilkie, Laura White, Elisabeth Dupont, Alan Cantor, Charles E Cox. Am J Surg 2005
91
27

Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ.
Lisa A Rutstein, Ronald R Johnson, William R Poller, David Dabbs, Jan Groblewski, Tina Rakitt, Allan Tsung, Thomas Kirchner, Jules Sumkin, Donald Keenan,[...]. Breast J 2007
44
24

Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only.
Mary F Dillon, Enda W McDermott, Cecily M Quinn, Ann O'Doherty, Niall O'Higgins, Arnold D K Hill. J Surg Oncol 2006
70
24


Mammographic size of ductal carcinoma in situ does not predict the presence of an invasive focus.
Y Wahedna, A J Evans, S E Pinder, I O Ellis, R W Blamey, J G Geraghty. Eur J Cancer 2001
27
22

Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
P Meijnen, H S A Oldenburg, C E Loo, O E Nieweg, J L Peterse, E J T Rutgers. Br J Surg 2007
61
20



Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer.
Min Yi, Savitri Krishnamurthy, Henry M Kuerer, Funda Meric-Bernstam, Isabelle Bedrosian, Merrick I Ross, Frederick C Ames, Anthony Lucci, Rosa F Hwang, Kelly K Hunt. Am J Surg 2008
47
20

Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy.
Hyung Seok Park, Seho Park, Junghoon Cho, Ji Min Park, Seung Il Kim, Byeong-Woo Park. J Surg Oncol 2013
40
20

Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy.
Elizabeth A Mittendorf, Cletus A Arciero, Veronica Gutchell, Jeff Hooke, Craig D Shriver. Curr Surg 2005
64
20

Predictors of invasion in needle core biopsies of the breast with ductal carcinoma in situ.
Edna May L Go, Siu-Ki Chan, Joaquim S L Vong, Philip C W Lui, Anthony W H Chan, Tony K F Ma, Mark A Ang, Bonita K B Law, Puay-Hoon Tan, Gary M Tse. Mod Pathol 2010
19
31

Nonpalpable breast cancer: percutaneous diagnosis with 11- and 8-gauge stereotactic vacuum-assisted biopsy devices.
R F Brem, J M Schoonjans, S N Goodman, A Nolten, F B Askin, O M Gatewood. Radiology 2001
55
20

Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update.
Gary H Lyman, Sarah Temin, Stephen B Edge, Lisa A Newman, Roderick R Turner, Donald L Weaver, Al B Benson, Linda D Bosserman, Harold J Burstein, Hiram Cody,[...]. J Clin Oncol 2014
458
20

Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.
Lotte E Elshof, Konstantinos Tryfonidis, Leen Slaets, A Elise van Leeuwen-Stok, Victoria P Skinner, Nicolas Dif, Ruud M Pijnappel, Nina Bijker, Emiel J Th Rutgers, Jelle Wesseling. Eur J Cancer 2015
172
20

Addressing overtreatment of screen detected DCIS; the LORIS trial.
Adele Francis, Jeremy Thomas, Lesley Fallowfield, Matthew Wallis, John M S Bartlett, Cassandra Brookes, Tracy Roberts, Sarah Pirrie, Claire Gaunt, Jennie Young,[...]. Eur J Cancer 2015
181
20

A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with ductal carcinoma in situ of the breast.
Takafumi Kondo, Naoki Hayashi, Sachiko Ohde, Koyu Suzuki, Atsushi Yoshida, Hiroshi Yagata, Naoki Niikura, Takayuki Iwamoto, Kumiko Kida, Michiko Murai,[...]. J Surg Oncol 2015
21
28

Accuracy and underestimation of malignancy of breast core needle biopsy: the Florence experience of over 4000 consecutive biopsies.
Stefano Ciatto, Nehmat Houssami, Daniela Ambrogetti, Simonetta Bianchi, Rita Bonardi, Beniamino Brancato, Sandra Catarzi, Gabriella G Risso. Breast Cancer Res Treat 2007
88
17

American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.
Gary H Lyman, Armando E Giuliano, Mark R Somerfield, Al B Benson, Diane C Bodurka, Harold J Burstein, Alistair J Cochran, Hiram S Cody, Stephen B Edge, Sharon Galper,[...]. J Clin Oncol 2005
17

Role of sentinel lymph node biopsy in ductal carcinoma-in-situ treated by mastectomy.
Jensen C C Tan, David R McCready, Alexandra M Easson, Wey L Leong. Ann Surg Oncol 2007
44
17

The finding of invasive cancer after a preoperative diagnosis of ductal carcinoma-in-situ: causes of ductal carcinoma-in-situ underestimates with stereotactic 14-gauge needle biopsy.
Lidewij E Hoorntje, Marguerite E I Schipper, Petra H M Peeters, Frank Bellot, Remmert K Storm, Inne H M Borel Rinkes. Ann Surg Oncol 2003
66
17

Accuracy of 11-gauge vacuum-assisted core biopsy of mammographic breast lesions.
Steven Pandelidis, David Heiland, David Jones, Kelly Stough, Joanne Trapeni, Yasir Suliman. Ann Surg Oncol 2003
66
17

Ductal carcinoma in situ and sentinel lymph node biopsy.
Bok Kyoung Son, Jin Gu Bong, Sung Hwan Park, Young Ju Jeong. J Breast Cancer 2011
18
27

Role of sentinel lymph node biopsy in high-risk ductal carcinoma in situ patients.
Cathal J Moran, Malcolm R Kell, Fidelma L Flanagan, Maria Kennedy, Thomas F Gorey, Michael J Kerin. Am J Surg 2007
34
17


Development and evaluation of a prediction model for underestimated invasive breast cancer in women with ductal carcinoma in situ at stereotactic large core needle biopsy.
Suzanne C E Diepstraten, Stephanie M W Y van de Ven, Ruud M Pijnappel, Petra H M Peeters, Maurice A A J van den Bosch, Helena M Verkooijen, Sjoerd G Elias. PLoS One 2013
11
45

Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy.
Laura Chin-Lenn, Lloyd A Mack, Walley Temple, William Cherniak, Robert R Quinn, Pietro Ravani, Adriane M Lewin, May Lynn Quan. Ann Surg Oncol 2014
23
21

Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast.
B Ansari, S A Ogston, C A Purdie, D J Adamson, D C Brown, A M Thompson. Br J Surg 2008
65
17

Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
Beth A Virnig, Todd M Tuttle, Tatyana Shamliyan, Robert L Kane. J Natl Cancer Inst 2010
364
17

A mass on breast imaging predicts coexisting invasive carcinoma in patients with a core biopsy diagnosis of ductal carcinoma in situ.
T A King, G H Farr, G J Cederbom, D H Smetherman, J S Bolton, A J Stolier, G M Fuhrman. Am Surg 2001
44
13

Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: can invasion be predicted?
C H Lee, D Carter, L E Philpotts, M E Couce, L J Horvath, R C Lange, I Tocino. Radiology 2000
109
13

Epidemiology of ductal carcinoma in situ.
Karla Kerlikowske. J Natl Cancer Inst Monogr 2010
117
13

A nomogram for predicting underestimation of invasiveness in ductal carcinoma in situ diagnosed by preoperative needle biopsy.
Hyung Seok Park, Ha Yan Kim, Seho Park, Eun-Kyung Kim, Seung Il Kim, Byeong-Woo Park. Breast 2013
25
16

Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of ductal carcinoma in situ: is it justified?
B Doyle, M Al-Mudhaffer, M M Kennedy, A O'Doherty, F Flanagan, E W McDermott, M J Kerin, A D Hill, C M Quinn. J Clin Pathol 2009
28
14

The impact of sentinel lymph node biopsy in patients with a core biopsy diagnosis of ductal carcinoma in situ.
Wai Ka Hung, Marcus Ying, Miranda Chan, Kong Ling Mak, Lap Kin Chan. Breast Cancer 2010
14
28

Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?
C E Cox, K Nguyen, R J Gray, C Salud, N N Ku, E Dupont, L Hutson, E Peltz, G Whitehead, D Reintgen,[...]. Am Surg 2001
165
13

Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?
N Klauber-DeMore, L K Tan, L Liberman, S Kaptain, J Fey, P Borgen, A Heerdt, L Montgomery, M Paglia, J A Petrek,[...]. Ann Surg Oncol 2000
226
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.